Slamon Dennis
SEC CIK 1603265 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BMRN | BIOMARIN PHARMACEUTICAL INC | Dir | 31.3K | — | $501.0K | 5 | 2022-02-28 | 2024-03-18 |
Most active insiders at BMRN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Davis George Eric | EVP, CLO | — | $2.76M |
| 2 | Guyer Charles Greg | EVP, Chief Technical Off | — | $996.7K |
| 3 | Friberg Gregory R | EVP, Chief R, D Off | — | $558.6K |
| 4 | Ramchandani Rashmi Virendra | VP, CAO | — | — |
| 5 | Hubbard Cristin | EVP, Chief Commercial Off | — | — |
| 6 | Hardy Alexander | CEO, Dir | — | — |
| 7 | Plenge Robert M | Dir | — | — |
| 8 | ANDERSON ELIZABETH M | Dir | — | — |
| 9 | Bodem Barbara W. | Dir | — | — |
| 10 | Ho Maykin | Dir | — | — |
Slamon Dennis made no open-market trades at BMRN in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-20 | 2024-03-18 | BMRN | BIOMARIN PHARMACEUTICAL INC | Slamon Dennis | Dir | F - Tax | $83.81 | -9,510 | 31.3K | -23% | -$797.0K |
| D | 2024-03-20 | 2024-03-18 | BMRN | BIOMARIN PHARMACEUTICAL INC | Slamon Dennis | Dir | M - OptEx | $79.70 | +10.0K | 40.8K | +32% | +$797.0K |
| 2023-05-24 | 2023-05-23 | BMRN | BIOMARIN PHARMACEUTICAL INC | Slamon Dennis | Dir | A - Grant | $0.00 | +4,190 | 30.8K | +16% | $0 | |
| 2022-05-26 | 2022-05-24 | BMRN | BIOMARIN PHARMACEUTICAL INC | Slamon Dennis | Dir | A - Grant | $0.00 | +4,980 | 26.6K | +23% | $0 | |
| M | 2022-03-02 | 2022-02-28 | BMRN | BIOMARIN PHARMACEUTICAL INC | Slamon Dennis | Dir | S - Sale | $78.33 | -6,396 | 21.6K | -23% | -$501.0K |
Purchase Sale Sale after option exercise All abbreviations